How to buy OPKO Health shares | $3.13

OPKO Health, Inc is a diagnostics & research business with stocks listed in the US. OPKO Health shares (OPK) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$3.13 – an increase of 4.68% over the previous week.

How to buy shares in OPKO Health

1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
3. Search for OPKO Health. Find the share by name or ticker symbol: OPK. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until OPKO Health reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of US$3.13, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of OPKO Health, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of OPKO Health. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted OPKO Health's share price?

Since the stock market crash in March caused by coronavirus, OPKO Health's share price has had significant positive movement.

Its last market close was US$3.13, which is 47.92% up on its pre-crash value of US$1.63 and 137.12% up on the lowest point reached during the March crash when the shares fell as low as US$1.32.

If you had bought US$1,000 worth of OPKO Health shares at the start of February 2020, those shares would have been worth US$933.34 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth US$2,086.68.

OPKO Health share price

Use our graph to track the performance of OPK stocks over time.

OPKO Health shares at a glance

• Key figures

Information last updated 2020-09-20.

Latest market close	USD$3.13
52-week range	USD$1.1171 - USD$6.47
50-day moving average	USD$4.1503
200-day moving average	USD$3.0053
Target price	USD$8
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.424

Get $0 brokerage on US stocks with trades as little as $50 when you join the world’s biggest social trading network.

eToro Share Trading (US stocks)

USD 0

Standard brokerage - US shares

Get $0 brokerage on US stocks with trades as little as $50 when you join the world’s biggest social trading network.

• $0 brokerage for US stocks
• Trades starting from $50
• Fractional shares
• Copy top traders

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy OPKO Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of OPKO Health, Inc by TradingView

OPKO Health price performance over time

Historical closes compared with the last close of $3.13

1 week (2020-09-14)	-1.26%
1 month (2020-08-21)	-35.60%
3 months (2020-06-19)	31.51%
6 months (2020-03-20)	123.57%

1 year (2019-09-20)	54.95%
2 years (2018-09-21)	-27.55%
3 years (2017-09-21)	-51.70%
5 years (2015-09-21)	-68.51%

Is OPKO Health under- or over-valued?

Valuing OPKO Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of OPKO Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

OPKO Health's EBITDA

OPKO Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$17.3 million (£0.0 million).

The EBITDA is a measure of a OPKO Health's overall financial performance and is widely used to measure a its profitability.

OPKO Health financials

Revenue TTM	US$965.8 million
Gross profit TTM	US$264.9 million
Return on assets TTM	-1.92%
Return on equity TTM	-12.12%
Profit margin	-20.69%
Book value	2.371
Market capitalisation	US$2.1 billion

TTM: trailing 12 months

Shorting OPKO Health shares

There are currently 129.5 million OPKO Health shares held short by investors – that's known as OPKO Health's "short interest". This figure is 10.7% up from 117.0 million last month.

There are a few different ways that this level of interest in shorting OPKO Health shares can be evaluated.

OPKO Health's "short interest ratio" (SIR)

OPKO Health's "short interest ratio" (SIR) is the quantity of OPKO Health shares currently shorted divided by the average quantity of OPKO Health shares traded daily (recently around 16.2 million). OPKO Health's SIR currently stands at 7.99. In other words for every 100,000 OPKO Health shares traded daily on the market, roughly 7990 shares are currently held short.

However OPKO Health's short interest can also be evaluated against the total number of OPKO Health shares, or, against the total number of tradable OPKO Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OPKO Health's short interest could be expressed as 0.19% of the outstanding shares (for every 100,000 OPKO Health shares in existence, roughly 190 shares are currently held short) or 0.3251% of the tradable shares (for every 100,000 tradable OPKO Health shares, roughly 325 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against OPKO Health.

Find out more about how you can short OPKO Health stock.

OPKO Health share dividends

We're not expecting OPKO Health to pay a dividend over the next 12 months.

OPKO Health share price volatility

Over the last 12 months, OPKO Health's shares have ranged in value from as little as US$1.1171 up to US$6.47. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OPKO Health's is 2.068. This would suggest that OPKO Health's shares are significantly more volatile than the average for this exchange and represent a higher risk.

OPKO Health overview

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase IIb trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.

Frequently asked questions

• What percentage of OPKO Health is owned by insiders or institutions?

  Currently 39.854% of OPKO Health shares are held by insiders and 26.356% by institutions.

• When does the fiscal year end for OPKO Health?

  OPKO Health's fiscal year ends in December.

• Where is OPKO Health based?

  OPKO Health's address is: 4400 Biscayne Boulevard, Miami, FL, United States, 33137

• What is OPKO Health's ISIN number?

  OPKO Health's international securities identification number is: US68375N1037

• What is OPKO Health's CUSIP number?

  OPKO Health's Committee on Uniform Securities Identification Procedures number is: 23282G105